Cargando…
Impact of New Systemic Treatment and Radiotherapy in Melanoma Patients with Leptomeningeal Metastases
SIMPLE SUMMARY: Although the recent years have seen incredible progress in the treatment of advanced melanoma including brain metastases, the survival of melanoma patients with leptomeningeal disease (LM) is still poor. There are currently only a handful of reports suggesting that BRAF and MEK inhib...
Autores principales: | Tétu, Pauline, Sirven-Villaros, Lila, Cuzzubbo, Stefania, Ursu, Renata, Baroudjian, Barouyr, Delyon, Julie, Nataf, François, De Margerie-Mellon, Constance, Allayous, Clara, Lefevre, Wendy, Carpentier, Antoine F., Lebbé, Céleste |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564430/ https://www.ncbi.nlm.nih.gov/pubmed/32947841 http://dx.doi.org/10.3390/cancers12092635 |
Ejemplares similares
-
Reintroduction of immune-checkpoint inhibitors after immune-related meningitis: a case series of melanoma patients
por: Cuzzubbo, Stefania, et al.
Publicado: (2020) -
Sonidegib in the Treatment of Locally Advanced Basal Cell Carcinoma: A Retrospective Study
por: HERMS, Florian, et al.
Publicado: (2022) -
18FDG PET Assessment of Therapeutic Response in Patients with Advanced or Metastatic Melanoma Treated with First-Line Immune Checkpoint Inhibitors
por: Rivas, Alexia, et al.
Publicado: (2022) -
Increased risk of brain metastases among patients with melanoma and PROM2 expression in metastatic lymph nodes
por: Nguyen, Thuy Thi, et al.
Publicado: (2020) -
Yield of FDG PET/CT for Defining the Extent of Disease in Patients with Kaposi Sarcoma
por: Pesqué, Louise, et al.
Publicado: (2022)